HIV Prevention Live 2016

HIV PRevention 2016

About the Program:

Program Overview
Learning Objectives
Program Dates
Faculty
Target Audience
Accreditation Statement
Credit Designation
Disclosure of Conflicts of Interest
Sunshine Act

Program Overview:

While there has been significant progress in the prevention of new HIV infections, transmission of HIV continues. Clearly, more needs to be done to reduce the rate of new infections through such approaches as increased HIV testing, behavioral interventions and the use of pre-exposure prophylaxis (PrEP). However, many clinicians are not fully equipped to guide their patients through the complex issues associated with HIV prevention. This situation results in patients not receiving optimal preventative care as described in national guidelines and to an increased number of people becoming infected with HIV who might otherwise not be infected. This educational program has been designed to address these challenges.

These interactive, case-based programs will educate clinicians who work with various patient populations - especially high-risk patients - about the theoretical framework, latest findings and ongoing research in HIV Prevention, and to review the professional guidelines in this area. In addition, this program will provide clinicians with a variety of HIV prevention management and treatment strategies for use with their patients, which is expected to help reduce the number of new HIV infections.

This program will also use a blending learning format. Participants attending these live programs will be asked to view the online CME course prior to the program date. This will maximize the learning experience and allow for greater discussion and interaction among the audience.

Back to Top

Learning Objectives:

Upon completion of the program, participants should be able to:

Recognize in clinical practice risk factors that contribute to the continued spread of HIV, especially in high-risk populations;
Apply in clinical practice strategies to reduce the risk of new infections with HIV in various populations;
Explain the rationale behind various behavioral and medical prevention strategies, including how research findings on these approaches can be applied to clinical practice;
Clinically apply findings and ongoing research on the use of vaccines, pre-exposure prophylaxis, post-exposure prophylaxis, and other prevention strategies in various populations;
Discuss with patients methods to minimize the spread of HIV infection.

Back to Top

Program Dates (Click Date/City to Register):

Wednesday, September 7, 2016 New York, NY	Tuesday, September 13, 2016 Chicago, IL
Wednesday, September 7, 2016 Los Angeles, CA	Wednesday, September 14, 2016 Miami, FL
Thursday, September 8, 2016 San Francisco, CA	Tuesday, September 20, 2016 Houston, TX

Faculty:

Richard A. Elion, MD
Associate Professor of Clinical Medicine
George Washington University Medical Center
Washington, DC

Wilbert Jordan, MD
Medical Director
Charles Drew Medical Center
Los Angeles, California

Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine
at the University of Pennsylvania
Philadelphia, Pennsylvania

Back to Top

Target Audience:

This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.

Back to Top

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd,Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Back to Top

Credit Designation:

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest:

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Back to Top

Sunshine Act:

As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.